Guidewires Market Supported by Regulatory Approvals for New Devices

The global guidewires market was valued at USD 2.58 billion in 2023, and it is projected to grow to USD 3.77 billion by 2030, representing a compound annual growth rate (CAGR) of 5.5 % between 2024 and 2030. Growth is chiefly driven by rising incidence of urological disorders, peripheral artery disease (PAD) and cardiovascular diseases (CVD).

Key Market Trends & Insights

• Regionally, North America dominated, capturing approximately 35.2 % of the global market in 2023. The U.S. held a major portion of that regional share. From a product perspective, the coronary guidewires segment held the largest share in 2023, at 43.2 %.
• A key driver of market growth is the increasing adoption of minimally invasive surgical procedures. For instance, more patients and clinicians favour less-invasive approaches for interventions, which supports the demand for guidewires designed for efficient navigation and access during such procedures. Technological advancements also play a critical role: improved guidewire designs that integrate imaging modalities, robotics support and specialized coatings enhance procedural success rates and steerability in complex anatomies.
• In addition, demographic trends contribute. The growing geriatric population is susceptible to cardiovascular disease, ischemic conditions, vascular dementia and other related disorders. For example, by 2030 one out of every six people worldwide is expected to be 60 years or older.

Market Size & Forecast

• In 2023, the market size stood at USD 2.58 billion. Forecasts indicate that by 2030 the market will reach USD 3.77 billion, with a 2024–2030 CAGR of roughly 5.5 %. North America’s share in 2023 was the largest of any region at about 35.2 %.
• The prevalence of cardiovascular disorders globally underpins this growth. To illustrate: worldwide, of a population of 8.0 billion, nearly 620 million are estimated to live with heart and circulatory diseases. Each year around 60 million people develop heart or circulatory conditions. Angina pectoris affects an estimated 2 % to 7 % of the global population in 2024; in China alone, over 2.8 million cases were reported in 2023.
• Meanwhile, coronary artery disease accounts for approximately 4.1 million deaths annually in Europe, of which 82 % occur in those aged over 65. These statistics reflect the large patient base and clinical demand for high-performance guidewire solutions.
• So, the combination of disease prevalence, ageing populations, preference for minimally invasive techniques, and advances in guidewire technology underpin a substantial growth outlook through 2030.

Order a free sample PDF of the Guidewires Market Intelligence Study, published by Grand View Research.

Key Companies & Market Share Insight

The guidewires market exhibits competitive intensity with global players advancing through product innovation, partnerships, mergers and acquisitions, and geographical expansion.  The industry is marked by high research-and-development investment and significant regulatory oversight (e.g., from the U.S. FDA).

Recent examples of innovation include the introduction of a temporary pacing guidewire designed to support both valve delivery and ventricular bipolar pacing during TAVR and BAV procedures, signalling a move toward multifunctional guidewire systems.  Partnerships between companies are also advancing neurovascular guidewire technologies, combining sensor technology with device manufacturing expertise.  M&A is also prominent — for instance, the acquisition of one company by a major cardiovascular device player in June 2024, aimed at bolstering minimally invasive treatment portfolios.

From a segment-perspective, the coronary guidewires segment (43.2 % share in 2023) remains dominant, but the fastest-growing segment is neurovascular guidewires — supported by increasing incidence of conditions such as aneurysms, arteriovenous malformations and stroke, and complexity of intervention in neurovascular anatomy.  Regionally, while North America leads, the Asia Pacific region is projected to grow rapidly thanks to rising chronic disease burden, increasing healthcare expenditure, expanding elderly populations, and infrastructure investment.

Key Companies List

The major participants in the guidewires market include:

• Boston Scientific Corporation
• Medtronic
• Cook
• Braun
• Terumo Medical Corporation
• Abbott
• Stryker
• Teleflex Incorporated
• BD

Conclusion

In summary, the global guidewires market is on a steady growth trajectory, propelled by widespread cardiovascular and vascular disease prevalence, an aging global population, and the steady preference shift toward minimally invasive surgical interventions. Technological innovation and regulatory advancements are enhancing the performance and applicability of guidewires, while regional growth opportunities — especially in Asia Pacific — offer further expansion potential. Competitive dynamics remain strong with leading device manufacturers actively investing in R&D, alliances and acquisitions to secure leadership positions. The market is therefore poised for continued healthy growth through 2030.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.